The Lancet Diabetes and Endocrinology
Factor de Impacto - Análisis · Tendencia · Clasificación · Predicción
Factor de Impacto
2019-2020
25.34
Tendencia del Factor de Impacto
The Lancet Diabetes and Endocrinology Factor de Impacto
El Factor de Impacto 2019-2020 de The Lancet Diabetes and Endocrinology es 25.34, que se acaba de actualizar en 2020.
The Lancet Diabetes and Endocrinology - Journal Impact IF
The 2019-2020 Journal Impact IF of The Lancet Diabetes and Endocrinology is 25.34, which is just updated in 2020.
The highest Factor de Impacto of The Lancet Diabetes and Endocrinology is 25.34.
The lowest Factor de Impacto of The Lancet Diabetes and Endocrinology is 9.185.
The total growth rate of The Lancet Diabetes and Endocrinology IF is 175.9%.
The annual growth rate of The Lancet Diabetes and Endocrinology IF is 29.3%.
Clasificación del Factor de Impacto
| Subcategoría | Cuartil | Rango | Porcentaje |
|---|---|---|---|
| Internal Medicine | Q1 | 1/128 |
Internal Medicine 99% |
| Endocrinology, Diabetes and Metabolism | Q1 | 1/217 |
Endocrinology, Diabetes and Metabolism 99% |
| Endocrinology | Q1 | 1/118 |
Endocrinology 99% |
· In the Internal Medicine research field, the Quartile of The Lancet Diabetes and Endocrinology is Q1. The Lancet Diabetes and Endocrinology has been ranked #1 over 128 related journals in the Internal Medicine research category. The ranking percentile of The Lancet Diabetes and Endocrinology is around 99% in the field of Internal Medicine.
The Lancet Diabetes and Endocrinology Key Factor Analysis
· In the Endocrinology, Diabetes and Metabolism research field, the Quartile of The Lancet Diabetes and Endocrinology is Q1. The Lancet Diabetes and Endocrinology has been ranked #1 over 217 related journals in the Endocrinology, Diabetes and Metabolism research category. The ranking percentile of The Lancet Diabetes and Endocrinology is around 99% in the field of Endocrinology, Diabetes and Metabolism.
The Lancet Diabetes and Endocrinology Key Factor Analysis
· In the Endocrinology research field, the Quartile of The Lancet Diabetes and Endocrinology is Q1. The Lancet Diabetes and Endocrinology has been ranked #1 over 118 related journals in the Endocrinology research category. The ranking percentile of The Lancet Diabetes and Endocrinology is around 99% in the field of Endocrinology.
The Lancet Diabetes and Endocrinology Key Factor Analysis
Revista Académica Relacionada
Tendencia de Colaboración Internacional
Tendencia de Documentos Citados
Registro de Factor de Impacto
| Año | Factor de Impacto |
|---|---|
| Año | Factor de Impacto |
| 2019-2020 | 25.34 |
| 2018-2019 | 24.54 |
| 2017-2018 | 19.313 |
| 2016-2017 | 19.742 |
| 2015-2016 | 16.32 |
| 2014-2015 | 9.185 |
| 2013-2014 | - |
| 2012-2013 | - |
| 2011-2012 | - |
· The 2019-2020 Factor de Impacto of The Lancet Diabetes and Endocrinology is 25.34
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2018-2019 Factor de Impacto of The Lancet Diabetes and Endocrinology is 24.54
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2017-2018 Factor de Impacto of The Lancet Diabetes and Endocrinology is 19.313
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2016-2017 Factor de Impacto of The Lancet Diabetes and Endocrinology is 19.742
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2015-2016 Factor de Impacto of The Lancet Diabetes and Endocrinology is 16.32
The Lancet Diabetes and Endocrinology Key Factor Analysis
· The 2014-2015 Factor de Impacto of The Lancet Diabetes and Endocrinology is 9.185
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Factor de Impacto 2013-2014 of The Lancet Diabetes and Endocrinology is still under analysis. Stay Tuned!
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Factor de Impacto 2012-2013 of The Lancet Diabetes and Endocrinology is still under analysis. Stay Tuned!
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Factor de Impacto 2011-2012 of The Lancet Diabetes and Endocrinology is still under analysis. Stay Tuned!
The Lancet Diabetes and Endocrinology Key Factor Analysis
Introducción
Each monthly issue of The Lancet Diabetes & Endocrinology features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. The journal publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.
The ISSN of The Lancet Diabetes and Endocrinology is
2213-8587
.
An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The ISSN (Online) of The Lancet Diabetes and Endocrinology is
2213-8595
.
An ISSN is an 8-digit code used to identify newspapers, journals, magazines and periodicals of all kinds and on all media–print and electronic.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Lancet Diabetes and Endocrinology is published by
Elsevier BV
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Lancet Diabetes and Endocrinology publishes reports
-
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Publication History of The Lancet Diabetes and Endocrinology covers
2013 - Present
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The Lancet Diabetes and Endocrinology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles. Anyone who wants to use the articles in any way must obtain permission from the publishers.
The Lancet Diabetes and Endocrinology Key Factor Analysis
There is no publication fee for submiting manuscript to The Lancet Diabetes and Endocrinology. The Lancet Diabetes and Endocrinology is Subscription-based (non-OA) Journal. Publishers own the rights to the articles in their journals. Anyone who wants to read the articles should pay by individual or institution to access the articles.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The language of The Lancet Diabetes and Endocrinology is
-
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
The publisher of The Lancet Diabetes and Endocrinology is
Elsevier BV
,
which locates in
Netherlands
.
The Lancet Diabetes and Endocrinology Key Factor Analysis
Revista Académica Popular
¿Qué es el factor de impacto?
El factor de impacto (FI) se utiliza con frecuencia como indicador de la importancia de una revista en su campo. Fue presentado por primera vez por Eugene Garfield, el fundador del Instituto de Información Científica. Aunque las instituciones y los médicos utilizan ampliamente la FI, las personas tienen una idea errónea generalizada sobre el método para calcular la FI de la revista, su importancia y cómo se puede utilizar. El FI de una revista no está asociado a factores como la calidad del proceso de revisión por pares y la calidad del contenido de la revista, sino que es una medida que refleja el número promedio de citas a artículos publicados en revistas, libros, tesis, informes de proyectos, periódicos. , actas de conferencias / seminarios, documentos publicados en Internet, notas y cualquier otro documento aprobado.
El factor de impacto se usa comúnmente para evaluar la importancia relativa de una revista dentro de su campo y para medir la frecuencia con la que el “artículo promedio” en una revista ha sido citado en un período de tiempo particular. La revista que publique más artículos de revisión obtendrá los IF más altos. Se cree que las revistas con FI más altas son más importantes que las que tienen menos. Según Eugene Garfield, "el impacto simplemente refleja la capacidad de las revistas y los editores para atraer el mejor artículo disponible". La revista que publique más artículos de revisión obtendrá el máximo de IF.
What is Impact Factor?
The impact factor (IF) is frequently used as an indicator of the importance of a journal to its field. It was first introduced by Eugene Garfield, the founder of the Institute for Scientific Information. Although IF is widely used by institutions and clinicians, people have widespread misconception regarding the method for calculating the journal IF, its significance and how it can be utilized. The IF of a journal is not associated to the factors like quality of peer review process and quality of content of the journal, but is a measure that reflects the average number of citations to articles published in journals, books, thesis, project reports, newspapers, conference/seminar proceedings, documents published in internet, notes, and any other approved documents.
Impact factor is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency with which the “average article” in a journal has been cited in a particular time period. Journal which publishes more review articles will get highest IFs. Journals with higher IFs believed to be more important than those with lower ones. According to Eugene Garfield “impact simply reflects the ability of the journals and editors to attract the best paper available.” Journal which publishes more review articles will get maximum IFs. The Journal Impact of an academic journal is a scientometric Metric that reflects the yearly average number of citations that recent articles published in a given journal received. It is frequently used as a Metric for the relative importance of a journal within its field; journals with higher Journal Impact are often deemed to be more important than those with lower ones. The The Lancet Diabetes and Endocrinology Factor de Impacto measures the average number of citations received in a particular year (2020) by papers published in the The Lancet Diabetes and Endocrinology during the two preceding years (2018-2019). Note that 2020 Journal Impact are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. In addition to the 2-year Journal Impact, the 3-year Journal Impact can provide further insights and factors into the impact of The Lancet Diabetes and Endocrinology.